HPLC Method for the Simultaneous Determination of the UV-Filters Butyl Methoxy Dibenzoylmethane and Octocrylene in the Presence of Their Photodegradants
- 429 Downloads
Butyl methoxy dibenzoylmethane (BMDM) and octocrylene (OC), common UV-filters in sunscreen products are often used in combination. Together they provide broad spectrum photoprotection from exposure to both UVA- and UVB-light. These UV-filters may, however, undergo photodegradation and generate photodegradants, resulting in a potential loss of photoprotection. It is thus a concern that the photostability testing as described by the ICH Guideline Q1B is not a requirement for sunscreen products in Australia, Europe or the USA. UV-filter photodegradants have in addition been shown to be toxic, highlighting the importance of their separation from the parent UV-filters. An HPLC method was developed and validated to quantitatively determine a combination of these UV-filters in the presence of their photodegradants. Reverse-phase chromatography was employed, using a C18 column and an isocratic mobile phase consisting of methanol/water/acetic acid (89/10/1 v/v). Validation according to the ICH guidelines for linearity, accuracy, precision, sensitivity, specificity and robustness was confirmed. The developed and validated method was then successfully applied to the determination of BMDM and OC in an aqueous cream base, typically used in sunscreens, after photostability testing, according to the ICH Guideline Q1B. In addition, the diketo-enol ratio of BMDM in methanol-d 4 was determined by NMR and the two major photodegradants were identified by FTMS and LC–MS.
KeywordsHPLC UV-filter and photodegradants Butyl methoxy dibenzoylmethane Octocrylene Method validation Aqueous cream
JK would like to thank the School of Pharmacy and Molecular Science at James Cook University (JCU) for a scholarship and the Graduate Research School at JCU for a Graduate Research Scheme Grant in 2012.
- 6.ICH Harmonised Tripartite Guideline (1996) Stability testing: photostability testing of new drug substances and products Q1B. http://www.ich.org. Accessed 24 May 2013
- 7.European Commission (2006) Commission Recommendation of 22 September 2006 on the efficacy of sunscreen products and claims made relating thereto. http://www.colipa.eu. Accessed 07 June 2013
- 8.Therapeutic Goods Administration (2012) Australian Regulatory guidelines for sunscreens. http://www.tga.gov.au. Accessed 18 Dec 2012
- 9.US Department of Health and Human Services. Food and Drug Administration (2011) Labelling and effectiveness testing; sunscreen drug products for over-the-counter human use; final rule. vol Federal Register/Vol 76, No 117. http://www.gpo.gov. Accessed 07 June 2013
- 10.European Commission (2006) Standardisation mandate assigned to CEN concerning methods for testing efficacy of sunscreen products. http://www.ec.europa.eu. Accessed 07 June 2013
- 21.ICH Harmonised Tripartite Guideline (2005) Validation of analytical procedures: text and methodology Q2(R1). http://www.ich.org. Accessed 25 April 2013
- 23.Lanley CA, Belcher D (2008) FAST track pharmaceutical compounding and dispensing. Pharmaceutical Press, London, pp 91–105Google Scholar
- 24.Australian/New Zealand Standard™ (2012) Sunscreen products: evaluation and classification (AS/NZS 2604:2012). Standards Australia Limited/Standards New Zealand, SydneyGoogle Scholar
- 25.Crowther JB (2001) In: Ahuja S, Scypinski S (eds) Handbook of modern pharmaceutical analysis. Academic Press, San Diego, p 435Google Scholar
- 26.Dolan JW, Jupille TH (2011) John Dolan’s Masterclasses: HPLC troubleshooting and diagnostics-Seminar, MelbourneGoogle Scholar